Iron deficiency is the most common nutrient deficiency in the world, affecting over 20% of
premenopausal women worldwide. Oral iron supplementation is often the first‐line treatment …

Despite increasing use of targeted therapies to treat cancer, anemia remains a common
complication of cancer therapy. Physician concerns about the safety of intravenous (IV) iron …

A comprehensive discussion of haematological morphology In the newly revised Sixth
Edition of Blood Cells: A Practical Guide, expert haematologist Barbara J. Bain delivers a …

Total iron-binding capacity (TIBC) is a crucial laboratory test for diagnosing iron metabolism
disorders and inflammatory diseases.[1] Iron-binding capacity is the capacity at which …

The role of iron in the formation and functioning of erythrocytes, and to a lesser degree of
white blood cells, is well established, but the relationship between iron and platelets is less …

Introduction Data describing safety and tolerability of anticoagulation and antiplatelet
therapy in hereditary hemorrhagic telangiectasia (HHT), the second-most-common inherited …

Abstract Von Hippel–Lindau protein (VHL) is essential to hypoxic regulation of cellular
processes. VHL promotes proteolytic clearance of hypoxia‐inducible transcription factors …

Iron deficiency (ID) is globally prevalent, and apart from anemia is associated with
thrombocytosis. While considered benign, studies linking thrombotic events with prior ID …

Possible mechanistic insights into iron homeostasis role of the action of 4-aminoquinolines (chloroquine/hydroxychloroquine)
on Page 1 7565 aim of providing possible mode of action of CQ and HCQ in the …

Background Antithrombotic therapy (anticoagulation and antiplatelet therapy) is frequently
needed in patients with hereditary hemorrhagic telangiectasia (HHT); however, data …